Connect to other sites within the UBM Medica Network
Advancements in Gynecological Oncology
Could the approval of bevacizumab for advanced cervical cancer and platinum-resistant ovarian cancer last year lead to patient-specific therapies?
FDA Approves New Drug for Advanced Ovarian Cancer
The FDA has approved olaparib, to be marketed under the name Lynparza, for the treatment of advanced ovarian cancer related to defective BRCA genes.
New App Predicts Ovarian Tumor Cancer Risk
A new app, called ADNEX, helps distinguish between benign and malignant ovarian tumors, potentially improving triage and management decisions.
Use of the Robot for Adnexal Surgery May Not Be Best
New research looking at complication rates and cost for oophorectomy and cystectomy favors conventional laparoscopy over robotic surgery.
Maintenance Pazopanib in Ovarian Cancer: No Survival Benefit, High AEs
Maintenance therapy with pazopanib improved progression-free survival by 5.6 months in advanced ovarian cancer patients, according to results of a new study.
SGO Recommends Genetic Testing for Endometrial and Ovarian Cancer Patients
The Society of Gynecologic Oncology (SGO) recently issued two new clinical practice statements recommending genetic testing for all women with endometrial and ovarian cancers, regardless of family history.
Healthy Weight Trims Ovarian Cancer Risk
Being overweight increases a woman’s risk of ovarian cancer, according to a new comprehensive report. The finding offers a way to reduce the risk.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.